What is GNOM's market cap?

$105.78M, based on the Sep 28 close of $70.30.

Does Global X Genomics & Biotechnology ETF pay a dividend?

Yes. The latest regular dividend was $0.0579 per share (ex-date Jun 29), an annualised yield of 0.16%.

NASDAQ · GNOM

Global X Genomics & Biotechnology ETF (GNOM)

$70.30+0.14%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$70.30▲ 83.39% in range

Sep 29, 2025Low $38.34 · High $70.30Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Global X Genomics & Biotechnology ETF closed at $70.30 on Sep 28, up 0.14% — matching its 52-week closing high. Volume of 90.5K shares was 2.51× its 20-day average (well above normal).

Split-adjusted performance: +4.6% over one month, +69.4% over six months, +88.2% over one year.

Short interest was 5.9K shares at the Sep 15 settlement, down 82.9% from the prior report (1.0 days to cover).

Market cap$105.8M1.5M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yield0.16%$0.0579 last paid

52-week range37.35 – 70.300.0% from high

Volume90.5K2.51× 20-day avg

Volatility · 60d39.4%Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W +4.0%1M +4.6%3M +23.1%6M +69.4%YTD +54.7%1Y +88.2%3Y +70.5%5Y −24.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short5.9K−82.9% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d59.8%of daily volume

News about Global X Genomics & Biotechnology ETF

All news →

No recent articles focused on Global X Genomics & Biotechnology ETF.

Quick answers

What is GNOM's market cap?: $105.78M, based on the Sep 28 close of $70.30.
Does Global X Genomics & Biotechnology ETF pay a dividend?: Yes. The latest regular dividend was $0.0579 per share (ex-date Jun 29), an annualised yield of 0.16%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology